trial · primary record
SHR-A1811 Injection
Non Small Cell Lung Cancer
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 436 |
| Primary completion | 2032-03 |
| Primary endpoint | Progression-free survival (PFS) based on blinded independent central review (BICR) |
| Registry ID | NCT07896005 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:57.414Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07896005
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.